C Sorg1,2,3, J Göttler4,5, C Zimmer4. 1. Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Ismaningerstr. 22, 81675, München, Germany. c.sorg@lrz.tum.de. 2. Department of Psychiatry, Klinikum rechts der Isar, Technische Universität München, Ismaningerstr. 22, 81675, München, Germany. c.sorg@lrz.tum.de. 3. TUM-Neuroimaging Center of the Klinikum rechts der Isar, Technische Universität München, München, Germany. c.sorg@lrz.tum.de. 4. Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Ismaningerstr. 22, 81675, München, Germany. 5. TUM-Neuroimaging Center of the Klinikum rechts der Isar, Technische Universität München, München, Germany.
Abstract
PURPOSE: Multi-modal brain imaging provides different in vivo windows into the human brain and thereby different ways to characterize brain disorders. Particularly, resting-state functional magnetic resonance imaging facilitates the study of macroscopic intrinsic brain networks, which are critical for development and spread of neurodegenerative processes in different neurodegenerative diseases. The aim of the current study is to present and highlight some paradigmatic findings in intrinsic network-based pathophysiology of neurodegenerative diseases and its potential for new network-based multimodal tools in imaging diagnostics. METHODS: Qualitative review of selected multi-modal imaging studies in neurodegenerative diseases particularly in Alzheimer's disease (AD). RESULTS: Functional connectivity of intrinsic brain networks is selectively and progressively impaired in AD, with changes likely starting before the onset of symptoms in fronto-parietal key networks such as default mode or attention networks. Patterns of distribution and development of both amyloid-β plaques and atrophy are linked with network connectivity changes, suggesting that start and spread of pathology interacts with network connectivity. Qualitatively similar findings have been observed in other neurodegenerative disorders, suggesting shared mechanisms of network-based pathophysiology across diseases. CONCLUSION: Spread of neurodegeneration is intimately linked with the functional connectivity of intrinsic brain networks. These pathophysiological insights pave the way for new multi-modal network-based tools to detect and characterize neurodegeneration in individual patients.
PURPOSE: Multi-modal brain imaging provides different in vivo windows into the human brain and thereby different ways to characterize brain disorders. Particularly, resting-state functional magnetic resonance imaging facilitates the study of macroscopic intrinsic brain networks, which are critical for development and spread of neurodegenerative processes in different neurodegenerative diseases. The aim of the current study is to present and highlight some paradigmatic findings in intrinsic network-based pathophysiology of neurodegenerative diseases and its potential for new network-based multimodal tools in imaging diagnostics. METHODS: Qualitative review of selected multi-modal imaging studies in neurodegenerative diseases particularly in Alzheimer's disease (AD). RESULTS: Functional connectivity of intrinsic brain networks is selectively and progressively impaired in AD, with changes likely starting before the onset of symptoms in fronto-parietal key networks such as default mode or attention networks. Patterns of distribution and development of both amyloid-β plaques and atrophy are linked with network connectivity changes, suggesting that start and spread of pathology interacts with network connectivity. Qualitatively similar findings have been observed in other neurodegenerative disorders, suggesting shared mechanisms of network-based pathophysiology across diseases. CONCLUSION: Spread of neurodegeneration is intimately linked with the functional connectivity of intrinsic brain networks. These pathophysiological insights pave the way for new multi-modal network-based tools to detect and characterize neurodegeneration in individual patients.
Authors: Bharat B Biswal; Maarten Mennes; Xi-Nian Zuo; Suril Gohel; Clare Kelly; Steve M Smith; Christian F Beckmann; Jonathan S Adelstein; Randy L Buckner; Stan Colcombe; Anne-Marie Dogonowski; Monique Ernst; Damien Fair; Michelle Hampson; Matthew J Hoptman; James S Hyde; Vesa J Kiviniemi; Rolf Kötter; Shi-Jiang Li; Ching-Po Lin; Mark J Lowe; Clare Mackay; David J Madden; Kristoffer H Madsen; Daniel S Margulies; Helen S Mayberg; Katie McMahon; Christopher S Monk; Stewart H Mostofsky; Bonnie J Nagel; James J Pekar; Scott J Peltier; Steven E Petersen; Valentin Riedl; Serge A R B Rombouts; Bart Rypma; Bradley L Schlaggar; Sein Schmidt; Rachael D Seidler; Greg J Siegle; Christian Sorg; Gao-Jun Teng; Juha Veijola; Arno Villringer; Martin Walter; Lihong Wang; Xu-Chu Weng; Susan Whitfield-Gabrieli; Peter Williamson; Christian Windischberger; Yu-Feng Zang; Hong-Ying Zhang; F Xavier Castellanos; Michael P Milham Journal: Proc Natl Acad Sci U S A Date: 2010-02-22 Impact factor: 11.205
Authors: Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson Journal: Neuron Date: 2009-07-30 Impact factor: 17.173
Authors: Michela Pievani; Nicola Filippini; Martijn P van den Heuvel; Stefano F Cappa; Giovanni B Frisoni Journal: Nat Rev Neurol Date: 2014-10-07 Impact factor: 42.937
Authors: Patrick Sweeney; Hyunsun Park; Marc Baumann; John Dunlop; Judith Frydman; Ron Kopito; Alexander McCampbell; Gabrielle Leblanc; Anjli Venkateswaran; Antti Nurmi; Robert Hodgson Journal: Transl Neurodegener Date: 2017-03-13 Impact factor: 8.014